CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The DIASHUTTLE project focuses on creating a multifunctional nanotheranostic platform for colorectal cancer treatment. By integrating various therapeutic and diagnostic methods, this innovative approach aims to enhance treatment efficacy while minimizing side effects and improving patient-specific care.
Colorectal cancer accounted for 12.7% of all new cancer diagnosis and 12.4% of all deaths due to cancer in European Union in 2020.
Despite the advances in therapeutics, it is the most recurrent tumors in humans and third common cause of cancer-related deaths worldwide.
The current treatment options include chemotherapy, radiation and surgery that are invasive and have side-effects.
Also, the 1st and 2nd generation nanocarriers used in cancer therapy consisted of mono-component systems and failed…
CONSIGLIO NAZIONALE DELLE RICERCHE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Sweden, GOTEBORG
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
